Clinical Course of Relapsing Remitting Multiple Sclerosis Post-Natalizumab

Maximillian D.J. Fiander; Virender Bhan; Samuel A. Stewart; Natalie E. Parks

doi:10.1017/cjn.2019.42

Clinical Course of Relapsing Remitting Multiple Sclerosis Post-Natalizumab

Maximillian D.J. Fiander, Virender Bhan, Samuel A. Stewart, Natalie E. Parks

科研成果: 期刊稿件 › 文章 › 同行评审

源语言	英语
页（从-至）	455-458
页数	4
期刊	Canadian Journal of Neurological Sciences
卷	46
期	4
DOI	https://doi.org/10.1017/cjn.2019.42
出版状态	已出版 - 7月 1 2019
已对外发布	是

!!!ASJC Scopus Subject Areas

临床神经病学
神经病学

访问文件

10.1017/cjn.2019.42

其它文件与链接

引用此

@article{744cac990ba94ae0a10a67a9d4ce91d3,

title = "Clinical Course of Relapsing Remitting Multiple Sclerosis Post-Natalizumab",

keywords = "Disease modifying therapy, Fingolimod, Multiple sclerosis, Natalizumab, Survival analysis",

author = "Fiander, {Maximillian D.J.} and Virender Bhan and Stewart, {Samuel A.} and Parks, {Natalie E.}",

note = "Publisher Copyright: {\textcopyright} 2019 The Canadian Journal of Neurological Sciences Inc.",

year = "2019",

month = jul,

day = "1",

doi = "10.1017/cjn.2019.42",

language = "English",

volume = "46",

pages = "455--458",

journal = "Canadian Journal of Neurological Sciences",

issn = "0317-1671",

publisher = "Canadian Journal of Neurological Sciences",

number = "4",

}

TY - JOUR

T1 - Clinical Course of Relapsing Remitting Multiple Sclerosis Post-Natalizumab

AU - Fiander, Maximillian D.J.

AU - Bhan, Virender

AU - Stewart, Samuel A.

AU - Parks, Natalie E.

PY - 2019/7/1

Y1 - 2019/7/1

KW - Disease modifying therapy

KW - Fingolimod

KW - Multiple sclerosis

KW - Natalizumab

KW - Survival analysis

UR - http://www.scopus.com/inward/record.url?scp=85068825219&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85068825219&partnerID=8YFLogxK

U2 - 10.1017/cjn.2019.42

DO - 10.1017/cjn.2019.42

M3 - Article

C2 - 31113500

AN - SCOPUS:85068825219

SN - 0317-1671

VL - 46

SP - 455

EP - 458

JO - Canadian Journal of Neurological Sciences

JF - Canadian Journal of Neurological Sciences

IS - 4

ER -

Clinical Course of Relapsing Remitting Multiple Sclerosis Post-Natalizumab

!!!ASJC Scopus Subject Areas

访问文件

其它文件与链接

指纹

引用此